Radio and PodcastRadio and PodcastLive Radio & Podcasts
192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative artwork
Science & Medicine

192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative

HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast by Sean P. Kane, PharmD, BCPS

Jul 23, 202533:57Science & Medicine

In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique non-opioid mechanism of action and additional considerations for its use. Key Co...

About This Episode

192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative is an episode from HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast by Sean P. Kane, PharmD, BCPS. In this episode, we discuss the evidence, s...

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 23, 2025, 33:57 long, audio available.

Questions About This Episode

What is 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative about?

In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique non-opioid mechanism of action and additional considerations for its use. Key Concepts Suzetrigine is a first in its class NaV1.8 sodium channel blocker approved for short-term (14 days or less) pain relief in adults with moderate-to-severe pain. Unlike opioids, suzetrigine is non-sedating and non-dependence forming. Suzetrigine is taken as a whole pill without cutting, crushing, or chewing following a particular dosing schedule where the first dose is taken on an empty-stomach. The most common side effects of suzetrigine include pruritus, muscle spasms, increased CPK, rash, and transient (reversible) eGFR decrease. Suzetrigine goes through CYP3A metabolism and therefore has significant interactions with CYP3A inducers and inhibitors. Use with strong inhibitors and moderate to strong inducers is not recommended. Dose reduction of suzetrigine is required if used with moderate inhibitors of CYP3A. Although not formally adopted in a guideline recommendation, suzetrigine's current place in therapy can be moderate-to-severe acute pain relief in adult patients after NSAIDs/APAP options are exhausted, but before or in place of opioid therapy. References Bertoch T, D'Aunno D, McCoun J, et al. Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials. Anesthesiology. 2025;142(6):1085-1099. doi:10.1097/ALN.0000000000005460

Where can I listen to 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative?

You can listen to 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative from?

192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative is an episode from HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast by Sean P. Kane, PharmD, BCPS.

How long is this episode?

This episode is 33:57 long.

When was this episode published?

This episode was published on Jul 23, 2025.

Can I save 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast?

Yes. This page shows related episodes from HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative?

You can listen to 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative is from HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast by Sean P. Kane, PharmD, BCPS.

What are the episode details?

Published Jul 23, 2025 and 33:57 long